Driehaus Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Driehaus Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,013,087	Closed	-$25.7M	–	472
2020 Q2	$25.7M	Sell	1,013,087 -1,461	-0.1%	-$31.5K	0.63%	40
2020 Q1	$18.6M	Buy	1,014,548 +22,628	+2%	+$440K	0.62%	41
2019 Q4	$21.9M	Buy	+991,920	New	+$20M	0.58%	43
2014 Q2	–	Sell	-61,589	Closed	-$1.74M	–	652
2014 Q1	$1.74M	Buy	+61,589	New	+$2.29M	0.05%	347

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Driehaus Capital Management's DRNA Position: Q3 2020 in Review

Driehaus Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2020, closing a stake of 1,013,087 shares — an estimated $25.7M sold.

Driehaus Capital Management first reported a position in DRNA in Q1 2014 and held it in 4 quarters. The position peaked at $25.7M in Q2 2020. 172 funds tracked by Wall St. Rank hold DRNA as of Q3 2020.

Driehaus Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Driehaus Capital Management sold 1,013,087 Dicerna Pharmaceuticals, Inc. shares in Q3 2020, an estimated $25.7M.
Driehaus Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
Driehaus Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $25.7M in Q2 2020.
172 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2020.

Based on Driehaus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.